BioAge Labs (BIOA) Return on Capital Employed (2024 - 2026)

BioAge Labs has disclosed Return on Capital Employed across 3 years of filings, most recently posting 30.78% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 30.78%, down 578.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 30.78% (down 578.0% YoY), and the FY2025 annual result was 30.28%, up 1731.0% from the prior year.
• Return on Capital Employed came in at 30.78% for Q1 2026 at BioAge Labs, up from 33.15% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 24.43% in Q4 2024 to a low of 33.15% in Q4 2025.
• The 3-year median for Return on Capital Employed is 30.11% (2025), against an average of 28.97%.
• Across the five-year window, Return on Capital Employed tumbled 872 bps in 2025 and plunged 578 bps in 2026, its largest moves.
• BioAge Labs' Return on Capital Employed stood at 24.43% in 2024, then slumped by 36 bps to 33.15% in 2025, then grew by 7 bps to 30.78% in 2026.
• The last three Return on Capital Employed figures came in at 30.78% (Q1 2026), 33.15% (Q4 2025), and 31.03% (Q3 2025), per Business Quant data.